Chronic renal disease in spain: prevalence and related factors in persons with diabetes mellitus older than 64 years

Influence of diabetes mellitus on the biochemical parameters and outcomes of multiple myeloma

OBJECTIVE

The incidence of MM in most registries remains stable or showing only a slightly increase. However, prevalence of MM is increasing due to the increase in overall survival in the last two decades. The aim of this study was to observe changes in biochemical parameters during the diagnosis and treatment of MM.

METHODS

A retrospective analysis was made of the biochemical indicators, survival time, and related adverse events of 196 patients with MM.

RESULTS

Of the 196 patients with MM, 26 were diagnosed with DM (DM-MM group) at the first diagnosis, 31 with steroid-induced diabetes mellitus (SID-MM group) during treatment, and 139 without DM (MM group). There was no significant difference between the three groups in the mean age of onset, sex ratio, incidence of hypercalcemia, renal dysfunction, anemia, abnormal lactate dehydrogenase, and median value of D-dimer and fibrinogen during diagnosis and treatment. There was no significant difference in survival time between the SID-MM and MM groups, but there was a significant difference between the DM-MM and MM groups.

CONCLUSION

There was no significant difference between the three groups in the incidence of hypercalcemia, anemia, and renal function impairment. The survival time of patients with DM was shorter than that of patients without DM.

Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain

This study analyzed the prevalence, costs and economic impact of chronic kidney disease CKD in patients with T2D in a Spanish Health District using real-world data. Observational cross-sectional study in adult patients with T2D was through data extracted from the information systems of the Valencia Clínico–La Malvarrosa Health District in the year 2015. Patients were stratified with the KDIGO classification for CKD. Additionally, patients were assigned to Clinical Risk Groups (CRGs) according to multimorbidity. Direct costs of primary and specialized care, and medication were estimated. The prevalence of T2D in the database population (n = 28,345) was 10.8% (mean age (SD) = 67.8 years (13.9); 51.5% male). Up to 14.935 patients (52.6%) had data on kidney function. According to the KDIGO classification, 66.2% of the patients were at low risk of CKD, 20.6% at moderately increased risk, 7.9% at high risk, and 5.2% at very high risk. The average healthcare costs associated with these four risk groups were EUR 3437, EUR 4936, EUR 5899 and EUR 7389, respectively. The large number of T2D patients with CKD in the early stages of the disease generated a significant increase in direct healthcare costs. The economic impact could be mitigated by early and comprehensive therapeutic approaches.

Accelerated Kidney Aging in Diabetes Mellitus

With aging, the kidney undergoes inexorable and progressive changes in structural and functional performance. These aging-related alterations are more obvious and serious in diabetes mellitus (DM). Renal accelerated aging under DM conditions is associated with multiple stresses such as accumulation of advanced glycation end products (AGEs), hypertension, oxidative stress, and inflammation. The main hallmarks of cellular senescence in diabetic kidneys include cyclin-dependent kinase inhibitors, telomere shortening, and diabetic nephropathy-associated secretory phenotype. Lysosome-dependent autophagy and antiaging proteins Klotho and Sirt1 play a fundamental role in the accelerated aging of kidneys in DM, among which the autophagy-lysosome system is the convergent mechanism of the multiple antiaging pathways involved in renal aging under DM conditions. Metformin and the inhibitor of sodium-glucose cotransporter 2 are recommended due to their antiaging effects independent of antihyperglycemia, besides angiotensin-converting enzyme inhibitors/angiotensin receptor blockers. Additionally, diet intervention including low protein and low AGEs with antioxidants are suggested for patients with diabetic nephropathy (DN). However, their long-term benefits still need further study. Exploring the interactive relationships among antiaging protein Klotho, Sirt1, and autophagy-lysosome system may provide insight into better satisfying the urgent medical needs of elderly patients with aging-related DN.

Prevalencia de factores de riesgo para enfermedades crónicas no transmisibles en Perú

Introducción: La hipertensión arterial, diabetes, obesidad y dislipidemia y hábitos como tipo de alimentación, actividad física, consumo de alcohol y tabaco, son factores de riesgo para la adquisición de enfermedades crónicas no transmisibles. El objetivo de este estudio es determinar la prevalencia de los factores de riesgo, que se encuentran asociados a las enfermedades cardiovasculares, en la población de 18 a 64 años de edad residentes del distrito Ayacucho y establecer su asociación a factores conductuales modificables. Materiales y Método: Estudio descriptivo, transversal, correlacional. Se aplicó encuesta: “Modelo investigación, Factores de Riesgo de Enfermedades No Transmisibles y medición de calidad de vida en Salud” del Ministerio de Salud, a muestra de 412 personas. Se les tomó muestra de sangre (glicemia y perfil lipídico), antropometría (peso y talla) y presión arterial. Se analizaron los datos mediante prueba de Pearson. Resultados: 64.8 % de la población presentó al menos un factor de riesgo para sufrir de enfermedades cardiovasculares, con prevalencias del 29.9; 29.6; 14.6 y 7.8% para obesidad, dislipidemia, hipertensión arterial y diabetes, respectivamente. Los cuales significativamente (p< 0.05) aumentan con la edad, se presentan con mayor frecuencia en hombres, consumidores de alcohol, tabaco, mal alimentados y de baja actividad física. Conclusiones: Hipertensión arterial, diabetes, dislipidemia y condición de obesidad, están asociadas a factores de riesgo conductuales modificables, de tomarse acciones correctivas, se disminuirá el riesgo de adquirir enfermedades cardiovasculares, esta información debe emplearse en la evaluación del impacto de programas de intervención que se realicen en la Región. Como citar este artículo: Barboza Palomino Edward Eusebio. Prevalencia de factores de riesgo para enfermedades crónicas no transmisibles en Perú. Revista Cuidarte. 2020; 11(2): e1066. http://dx.doi.org/10.15649/cuidarte.1066

Factores relacionados con el inicio no programado de hemodiálisis en pacientes seguidos en consulta ERCA

Introducción. El inicio programado del tratamiento renal sustitutivo es un objetivo prioritario en el manejo de los pacientes con enfermedad renal crónica, ya que supone un gran impacto para la supervivencia de estos pacientes.Objetivo: Analizar características clínicas implicadas en el inicio no programado de la hemodiálisis en pa-cientes seguidos en consulta ERCA.Material y Método: Estudio retrospectivo observacio-nal en pacientes incidentes en el periodo 2014-2018. Se recogieron datos clínicos y sociodemográficos de la historia clínica del paciente, tiempo de seguimiento en consulta ERCA, filtrado glomerular al inicio de la con-sulta ERCA, causa y tipo de inicio (programado o no) de la hemodiálisis, así como el acceso vascular empleado.Resultados: Se incluyeron 168 pacientes incidentes seguidos en consulta ERCA. El 28,6% inició hemodiá-lisis de forma no programada. Los inicios programados se debieron a causa urémica y los no programados, a insuficiencia cardíaca (92% y 54% respectivamente, p<0,001). Los pacientes con inicio no programado utili-zaron un catéter en el 77% de las ocasiones (p<0,001), tenían más edad (69,27±9,4 vs 65,18±12,75 años) y un menor tiempo de seguimiento en la consulta ERCA (15,60±12,37 vs 23,64±20,25 meses) que los pacien-tes con inicio programado.Conclusiones: Pacientes de mayor edad, con menor tiempo de seguimiento en consulta ERCA tienen más riesgo de iniciar hemodiálisis de forma no programada a través de un catéter venoso central por falta de un acceso vascular definitivo.

Renal status in elderly patients with type 2 diabetes

BACKGROUND

In Japan, there has been a remarkable increase in the incidence of type 2 diabetes in elderly patients. This study aimed to clarify the renal status in elderly patients with type 2 diabetes.

PARTICIPANTS AND METHODS

There were 978 patients with type 2 diabetes who were classified into three groups: Group 1 (aged < 65 years of age), Group 2 (65-74 years of age), and Group 3 (≥ 75 years of age). Estimated glomerular filtration rate (eGFR) and urinary albumin level were measured. Moreover, the frequencies of each stage of chronic kidney disease for each group were determined, and differences among the three groups were analyzed.

RESULTS

The mean eGFR in Group 3 was 63.2 ± 19.1 mL/min/1.73 m2, which was lower than those in Group 1 (83.3 ± 22.8 mL/min/1.73 m2) and Group 2 (72.0 ± 19.4 mL/min/1.73 m2). The percentage of low eGFR (< 60 mL/min/1.73 m2) with normo- and microalbuminuria in Group 3 was 31.9%, which was higher than the percentages observed in Group 1 (7.1%) or Group 2 (16.1%). Diabetic macroangiopathy was frequently observed in these patients. The frequency of low eGFR with proteinuria was 10.2%. In this group, diabetic micro- and macroangiopathies were frequently noted.

CONCLUSION

In elderly patients with type 2 diabetes, renal dysfunction is characterized by low eGFR with normo- and microalbuminuria. In this group, macroangiopathy was more common than microangiopathy. The elderly patients with diabetes with low eGFR with proteinuria frequently had micro- and macroangiopathies.

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation

Type 2 diabetes (T2D) is an independent risk factor of stroke and systemic embolism in patients with atrial fibrillation (AF), and T2D patients with AF-associated stroke seem to have worse clinical outcome and higher risk of unfavorable clinical course compared to individuals without this metabolic disorder. Long-term anticoagulation is indicated in majority of T2D patients with AF to prevent adverse AF-associated embolic events. Direct oral anticoagulants (DOACs), direct oral thrombin inhibitor dabigatran, and direct oral factor Xa inhibitors, rivaroxaban, apixaban, and edoxaban, have emerged as a preferred choice for long-term prevention of stroke in AF patients offering potent and predictable anticoagulation and a favorable pharmacology with low risk of interactions. This article reviews the current data regarding the use of DOACs in individuals with T2D and AF.

Predictores de progresión de enfermedad renal en el paciente anciano

El riñón del anciano experimenta cambios estructurales y funcionales, que lo convierte en más vulnerable para la enfermedad renal. La mayoría de ancianos con enfermedad renal crónica fallece antes de desarrollar progresión renal. Sin embargo, el principal grupo de pacientes incidentes de nefropatía terminal es el de personas mayores de 65 años, representando la diabetes mellitus y las causas vasculares sus principales etiologías. En esta revisión se analizan elementos renales (filtrado glomerular, proteinuria/albuminuria, potasio, fracaso renal agudo y diuréticos) y factores geriátricos (estado funcional, cognitivo y fragilidad) como predictores de progresión de enfermedad renal. La identificación de estos factores contribuirá a establecer estrategias de prevención renal y al pronóstico de la enfermedad en la toma decisiones.

Analysis of the characteristics of patients with diabetes mellitus who attend a tertiary hospital emergency department for a hypoglycemic event

INTRODUCTION AND OBJECTIVE

Hypoglycemia associated to insulin or other glucose-lowering agents is one of the most common causes of visits to the emergency department for adverse drug reactions. The study objective was to analyze the characteristics of patients with diabetes mellitus (DM) who attend a tertiary hospital emergency department for a hypoglycemic event.

PATIENTS AND METHODS

A 3-year retrospective analysis was conducted of patients with DM who attended the emergency department of Hospital Universitari de Bellvitge for a hypoglycemic event. An analysis was made of epidemiological and diabetes-related characteristics, prevalence of chronic diabetic complications and other comorbidities, the glucose-lowering treatment and the result of the hypoglycemic episode.

RESULTS

Of the 149 hypoglycemic events analyzed, 81.9% occurred in patients with type 2 DM. Mean age of patients with type 2 DM was 75.4 years. DM duration was longer than 10 years in 69.4% of patients. The prevalence rates of chronic kidney disease and cognitive decline were 38.5% and 19.7% respectively in patients with type 2 DM. Insulin with or without other concomitant glucose-lowering agents was associated to 78.7% of episodes in type 2 DM patients. The remaining 21.3% were associated to oral hypoglycemic agents, mainly glibenclamide. After the event, 13.4% of patients required hospital admission, and in 36.8% of these hypoglycemia was associated to use of glibenclamide.

CONCLUSIONS

A majority of hypoglycemic events occurred in elderly patients with type 2 DM, with a high prevalence of associated comorbidities and treated with insulin and sulfonylureas, particularly glibenclamide.